Tesamorelin: Handling, Storage, and Reconstitution Guide

Tesamorelin is a synthetic, lyophilized 44-residue research peptide, and its performance in receptor and secretion assays depends on careful laboratory handling. This guide covers Tesamorelin storage, reconstitution, aliquoting, and documentation as laboratory best practice for in-vitro and animal-model preparation only. It is not human-use guidance.

Tesamorelin Storage and Cold Chain

Tesamorelin storage begins with the lyophilized powder. The material is kept sealed at or below 25 degrees Celsius, away from heat, light, and moisture, for short-term handling, while extended storage is best served by keeping the lyophilized peptide refrigerated or frozen. Cold, dry, dark conditions slow the chemical degradation pathways that affect peptides.

Although the trans-3-hexenoyl modification improves resistance to enzymatic cleavage, that stability applies to the intact peptide in a biological system and does not replace good storage practice. The lyophilized form remains markedly more stable than any reconstituted solution, so laboratories preserve the powder under validated conditions and maintain storage records to support the reproducibility discussed in our Tesamorelin research applications overview.

Reconstitution With Bacteriostatic Water

For in-vitro preparation, Tesamorelin is typically reconstituted with bacteriostatic water, added slowly down the inside wall of the vial rather than directly onto the powder. The vial is swirled gently until the peptide dissolves; vortexing and vigorous shaking are avoided because mechanical stress can degrade the peptide.

Reconstituted peptide is less stable than the lyophilized form, so preparations are handled promptly and kept cold. These preparation choices directly affect the GHRH-receptor and cAMP readouts described in the Tesamorelin mechanism of action overview.

It is worth reiterating that the enzymatic stability built into Tesamorelin does not translate into indefinite stability in aqueous solution. The trans-3-hexenoyl modification protects against a specific protease in biological systems, but the reconstituted peptide is still subject to the ordinary hydrolytic and oxidative processes that affect any peptide in water, so cold, prompt handling remains the rule.

• Reconstitute with bacteriostatic water for in-vitro prep
• Add solvent slowly along the vial wall
• Swirl gently; do not vortex
• Keep reconstituted solution cold and use promptly

Aliquoting to Limit Freeze-Thaw

Repeated freeze-thaw cycling is a common cause of peptide degradation, so aliquoting is the standard protective step. After reconstitution, the solution is divided into single-use volumes matched to the study design, allowing each experiment to draw from a fresh aliquot rather than repeatedly thawing a single stock.

Aliquots are labeled with lot number, concentration, and date and stored under validated conditions. This preserves peptide integrity and creates a clear chain of custody, the same discipline applied to the compact GHRH fragment studied alongside Tesamorelin, including the Sermorelin handling guide.

Concentration, Solubility, and Larger Vials

Working concentration is chosen to suit the assay while keeping the peptide comfortably in solution. Because Tesamorelin is supplied in larger 10 mg and 20 mg vials, the reconstitution volume is planned to yield a practical stock concentration, and researchers confirm the reconstituted material is clear and particulate-free before use. Recording the reconstitution volume against the labeled vial mass lets teams calculate stock concentration precisely.

Larger vials also mean that aliquoting discipline is especially valuable, since a single reconstituted vial may supply many experiments. Dividing the stock promptly protects the whole quantity from the freeze-thaw and temperature exposure that would otherwise accumulate over repeated use.

Planning the aliquot size around the study's typical experiment reduces waste and handling stress alike. When each aliquot corresponds to a single day's work, the remaining material stays frozen and untouched, which is the most reliable way to preserve activity across the extended timelines that larger vials tend to support.

Certificate of Analysis and Lot Verification

Each Tesamorelin batch ships with a third-party-verified certificate of analysis. The CoA documents purity by HPLC or reverse-phase chromatography, mass-spectrometry identity confirmation, and lot number, testing date, and method documentation, giving researchers transparent, research-grade quality control.

The mass-spectrometry data is a useful identity check, since it confirms the material matches the expected molecular weight of roughly 5136 g/mol for the stabilized GHRH(1-44) sequence. On receipt, teams cross-check the certificate against the vial label, record the lot number in inventory, and file the CoA for audit readiness; sample CoAs can be requested ahead of purchase.

Documentation, Traceability, and Ordering

Beyond the certificate, laboratories log handling activities, storage conditions, and reconstitution details so that every result can be traced back to a specific batch. This traceability mirrors the standards used for combined GHRH and ghrelin preparations such as those in the Tesamorelin plus Ipamorelin blend handling guide, and it is what allows data from different studies to be compared with confidence. Tesamorelin is supplied as a 10 mg or 20 mg lyophilized research vial intended for laboratory use, and maintaining material integrity from cold-chain receipt through careful reconstitution and aliquoting is the practical foundation for the reproducible GHRH-analog datasets the compound is used to generate.

For research use only. Not for human or veterinary use. All statements describe reported findings in preclinical and in-vitro research models and are provided for laboratory reference only.